We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neurones | EU:NRO | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 0.89% | 45.40 | 45.05 | 45.40 | 45.40 | 44.75 | 45.00 | 15,153 | 16:35:02 |
PRESS INFORMATION
Heading: 1st half 2013 results
Nanterre, September 11, 2013
1st half 2013 operating profit stands at 8.8%
Accounts at June 30 (audited in € millions) | H1 2013 | H1 2012 | 2012 |
Revenues | 168.5 | 155.4 | 315.4 |
Business operating profit (*) | 15.4 (9.2%) | 13.4 (8.7%) | 29.2 (9.3%) |
Operating profit | 14.8 (8.8%) | 12.7 (8.2%) | 28.1 (8.9%) |
Net financial income | 1.0 | 0.7 | 1.4 |
Corporate income tax | (6.1) | (6.0) | (12.3) |
Net profit after tax | 9.7 (5.8%) | 7.4 (4.8%) | 17.2 (5.4%) |
of which, group share | 8.3 | 6.3 | 14.9 |
Staff at end of period | 3,847 | 3,595 | 3,704 |
(*) Prior to cost of free shares, stock options and impairment of assets
Achievements
Over the period, NEURONES' revenues grew 8.4% (organic growth only).
The competitiveness and employment tax credit was the main driver for increased profitability. Operating profit accounted for 8.8% of revenues and net profit increased by 31%.
The Group's net cash also grew to €84.7 million, compared with €68.8 million on June 30, 2012.
Outlook
Overall, for 2013, NEURONES maintains its forecast to achieve annual revenues in excess of €335 million and an operating profit of between 8.5% and 9% of revenues.
About NEURONES
With 3,850 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years.
NYSE Euronext: Compartment B - ISIN code: FR0004050250 - NYSE symbol: NRO
www.neurones.net
Press Relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 fredg@fgcom.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
1 Year Neurones Chart |
1 Month Neurones Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions